Federal Register / Vol. 88, No. 245 / Friday, December 22, 2023 / Notices 88619 

1This estimate refers to the eight FMUs currently 

designated as systemically important under title 

VIII, as well as one additional respondent for 

purposes of illustrating the burden associated with 

12 CFR 1320.11, 12 CFR 1320.12, and 12 CFR 

1320.14. 

2This estimate refers to the eight FMUs currently 

designated as systemically important under title 

VIII, as well as three additional responses for 

purposes of illustrating the burden associated with 

12 CFR 1320.11, 12 CFR 1320.12, and 12 CFR 

1320.14. 

3The hour estimates refer, respectively, to 

information collections for respondents associated 

with 12 CFR 1320.20, 12 CFR 1320.11, 12 CFR 

1320.12, and 12 CFR 1320.14. 

opportunity to submit written materials 

to the Council in support of, or in 

opposition to, designation or rescission 

of designation. The collection of 

information under 12 CFR 1320.12 

affords FMUs an opportunity to contest 

a proposed determination of the Council 

by requesting a hearing and submitting 

written materials (or, at the sole 

discretion of the Council, oral testimony 

and oral argument). The collection of 

information in 12 CFR 1320.14 affords 

FMUs an opportunity to contest the 

Council’s waiver or modification of the 

notice, hearing, or other requirements 

contained in 12 CFR 1320.11 and 

1320.12 by requesting a hearing and 

submitting written materials (or, at the 

sole discretion of the Council, oral 

testimony and oral argument). The 

information collected from FMUs under 

12 CFR 1320.20 will be used by the 

Council to determine whether to 

designate an additional FMU or to 

rescind the designation of a designated 

FMU. 

Form: None. 

Affected Public: Businesses or other 

for-profit and not-for-profit institutions. 

Estimated Number of Respondents: 

9.1

Frequency of Response: On Occasion. 

Estimated Total Number of Annual 

Responses: 11.2

Estimated Time per Response: 50 

hours, 20 hours, 10 hours, 10 hours.3

Estimated Total Annual Burden 

Hours: 440. 

Request for Comments: Comments 

submitted in response to this notice will 

be summarized and/or included in the 

request for OMB approval. All 

comments will become a matter of 

public record. Comments are invited on: 

(a) whether the collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information has practical 

utility; (b) the accuracy of the agency’s 

estimate of the burden of the collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; (d) ways to 

minimize the burden of the collection of 

information on respondents, including 

through the use of automated collection 

techniques or other forms of information 

technology; and (e) estimates of capital 

or start-up costs and costs of operation, 

maintenance, and purchase of services 

to provide information. 

Authority: Public Law 104–13 (44 

U.S.C. 3506(c)(2)(A)). 

Dated: December 19, 2023. 

Samantha MacInnis, 

Director of Operations, Financial Stability 

Oversight Council. 

[FR Doc. 2023–28246 Filed 12–21–23; 8:45 am] 

BILLING CODE 4810–AK–P 

GENERAL SERVICES 

ADMINISTRATION 

[FMR Bulletin C–2024–01] 

Guidelines for Safety Station Programs 

in Federal Facilities 

AGENCY: Department of Health and 

Human Services and General Services 

Administration. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) and 

the U.S. General Services 

Administration (GSA) jointly issue this 

Federal Management Regulation (FMR) 

bulletin titled ‘‘Guidelines for Safety 

Station Programs in Federal Facilities.’’ 

These guidelines were prepared, in part, 

in response to congressional direction 

contained in materials that 

accompanied the Consolidated 

Appropriations Act, 2023 (Pub. L. 117– 

328). See the SUPPLEMENTARY

INFORMATION section for further details. 

DATES: December 22, 2023. 

FOR FURTHER INFORMATION CONTACT: For 

further clarification of content, contact 

Christopher Coneeney, Supervisory 

Realty Specialist, Office of Governmentwide Policy, U.S. General Services 

Administration, 1800 F Street NW, 

Washington, DC 20405; at 202–208– 

2956; or chris.coneeney@gsa.gov. 

SUPPLEMENTARY INFORMATION: A 

provision in House of Representatives 

Report No. 117–393, which 

accompanied the bill making 

appropriations for Financial Services 

and General Government for the fiscal 

year ending September 30, 2023 (the 

House Report), directed GSA, in 

coordination with HHS as the lead 

agency with health policy expertise, to 

update the FMR bulletin on Guidelines 

for Public Access Defibrillation 

Programs in Federal Facilities, which 

became effective on August 14, 2009 

(the 2009 Bulletin), to reflect advances 

in automated external defibrillator 

(AED) technologies and to examine 

whether AEDs should be required in 

Federally owned buildings under the 

custody and control of GSA. The report 

may be found at https://

www.congress.gov/117/crpt/hrpt393/ 

CRPT-117hrpt393.pdf. The House 

Report acknowledged that sudden 

cardiac arrest is a leading cause of death 

for Americans and that early 

intervention and timely use of an AED 

significantly improves the chances of 

survival. It further noted that, in 2001, 

Congress required the creation of a 

public access defibrillator (PAD) 

program that included voluntary 

guidelines for deployment of AEDs in 

Federal buildings and that, in 2009, 

GSA and HHS issued the abovereferenced FMR bulletin. 

In addition to the House Report, the 

joint explanatory statement 

accompanying division E—Financial 

Services and General Government 

Appropriations Act, 2023, of the 

Consolidated Appropriations Act, 2023 

(the Joint Explanatory Statement), 

directed HHS and GSA to examine 

whether AEDs should be required in 

federally owned buildings under the 

custody and control of GSA and to issue 

an updated FMR bulletin no later than 

one year after enactment of the 

Consolidated Appropriations Act, 2023. 

The link to the Joint Explanatory 

Statement can be found at https://

www.appropriations.senate.gov/imo/ 

media/doc/Division%20E%20- 

%20FSGG%20Statement%20FY23.pdf. 

Accordingly, this bulletin cancels and 

replaces in its entirety the 2009 Bulletin 

and provides updated information for 

establishing an agency safety station 

program, including public access AEDs, 

in Federally owned buildings under the 

jurisdiction, custody and control of 

GSA. 

The revised guidelines provide a 

general framework and basic 

information for the essential elements of 

designing and implementing a safety 

station program in Federal facilities and 

includes the latest updates in (a) PAD 

programs and AED technologies since 

the 2009 Bulletin issuance, (b) opioid 

reversal agents and (c) hemorrhagic 

control. Safety station program 

configurations are flexible and can be 

designed to accommodate all types of 

Federal facilities. The configurations are 

modular in nature and usually include 

bystander-empowered components with 

opioid reversal agents (such as 

naloxone) or hemorrhagic control (such 

as Stop the Bleed® kits), or both, in 

addition to AED technologies. The 

guidelines do not exhaustively address 

or cover all aspects of a safety station 

program. They are aimed at outlining 


ddrumheller on DSK120RN23PROD with NOTICES1
88620 Federal Register / Vol. 88, No. 245 / Friday, December 22, 2023 / Notices 

the key elements of a safety station 

program so that facility-specific detailed 

plans and programs can be developed in 

an informed manner. Safety station 

programs are voluntary and are not 

mandatory for Federal facilities. The 

costs and expenses to establish and 

operate a safety station program are the 

responsibility of the occupant agency or 

agencies sponsoring the program and 

not GSA or HHS, except to the extent 

GSA or HHS, or both, are sponsoring a 

program in a facility where they are 

occupant agencies. 

The importance of keeping opioid 

reversal agents easily accessible has 

been highlighted by the U.S. Surgeon 

General and the Centers for Disease 

Control and Prevention (CDC). On April 

5, 2018, Surgeon General Jerome Adams 

issued an advisory recommending that 

more individuals keep naloxone on 

hand. The link to the advisory can be 

found at https://www.hhs.gov/ 

surgeongeneral/reports-andpublications/addiction-and-substancemisuse/advisory-on-naloxone/ 

index.html. On October 5, 2018, the 

CDC’s National Institute for 

Occupational Safety and Health 

(NIOSH) issued the fact sheet ‘‘Using 

Naloxone to Reverse Opioid Overdose 

in the Workplace: Information for 

Employers and Workers’’ to assist 

workplace decision makers in 

establishing a naloxone availability and 

use program. The link to the white 

paper can be found at https://

www.cdc.gov/niosh/docs/2019-101/ 

pdfs/2019-101.pdf. The Surgeon General 

advisory and the CDC NIOSH fact sheet 

highlight the importance of having 

opioid reversal agents in public spaces 

for quick access and why they should be 

included in an agency’s safety station 

program. 

Krystal J. Brumfield, 

Associate Administrator, Office of 

Government-wide Policy, U.S. General 

Services Administration. 

Rachel L. Levine, 

Assistant Secretary for Health, U.S. 

Department of Health and Human Services. 

[FR Doc. 2023–28207 Filed 12–21–23; 8:45 am] 

BILLING CODE 6820–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–1074; Docket No. CDC–2023– 

0100] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Colorectal 

Cancer Control Program (CRCCP) 

Monitoring Activities. CDC is requesting 

an Extension to OMB Control No. 0920– 

1074 to continue information collection 

via an annual survey, a clinic-level data 

collection instrument, and a quarterly 

recipient-level program update survey. 

DATES: CDC must receive written 

comments on or before February 20, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0100 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Colorectal Cancer Control Program 

(CRCCP) Monitoring Activities (OMB 

Control No. 0920–1074, Exp. 03/31/ 

2024)—Extension—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Colorectal cancer (CRC) is the second 

leading cause of death from cancer in 

the United States among cancers that 

affect both men and women. There is 

substantial evidence that CRC screening 

reduces the incidence of, and death 

from the disease. Screening for CRC can 

detect disease early when treatment is 

more effective, and can prevent cancer 

by finding and removing precancerous 


ddrumheller on DSK120RN23PROD with NOTICES1